Pascal Biosciences Inc (PAS)
TSXV
Year End November 29 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 6k | 672k |
Operating Income | -1.47M | -1.59M | -3.29M | -2.84M | -983k | -786k | -291k | -622k |
Pre Tax Income | -1.56M | -1.66M | -3.24M | -3.41M | -1.24M | -1.09M | -480k | -400k |
Net Income | -1.56M | -1.66M | -3.24M | -3.41M | -1.24M | -1.09M | -480k | -400k |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.044 | -0.044 | -0.062 | -0.065 | -0.021 | -0.017 | -0.007 | -0.01 |
EBIT | -1.47M | -1.59M | -3.23M | -2.84M | -937k | -837k | -323k | -97k |
EBITDA | -1.38M | -1.5M | -2.49M | -2.83M | -971k | -770k | -283k | -515k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.